Literature DB >> 8456431

von Willebrand disease: a database of point mutations, insertions, and deletions. For the Consortium on von Willebrand Factor Mutations and Polymorphisms, and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.

D Ginsburg1, J E Sadler.   

Abstract

The current system for the diagnosis and classification of von Willebrand disease (vWD) is quite complex, with more than 20 distinct variants described. Over the past few years considerable progress has been made toward an understanding of vWD at the molecular level. A small cluster of mutations within the vWF A1 homologous repeat appears responsible for over 90% of type IIB vWD. A similar cluster of mutations in the vWF A2 homologous repeat accounts for the majority of type IIA vWD. By RFLP analysis, several type II vWD mutations have been shown to be recurrent on distinct haplotype backgrounds, suggesting independent genetic origins (see accompanying manuscript for a complete list of known polymorphisms). Several mutations at the N-terminus of the mature vWF subunit have been identified in association with abnormal factor VIII binding. Homozygotes for this abnormal vWF present with a hemophilia-like phenotype that is autosomal recessive in inheritance. In a small subset of patients with type III vWD large gene deletions have been identified on one or both vWF alleles. Carriers heterozygous for a deleted locus and one normal vWF gene are generally asymptomatic. Nonsense mutations and other defects resulting in loss of vWF mRNA expression from one allele have also been associated with a recessive type III vWD phenotype. No distinct molecular defect responsible for classic type I vWD has yet been defined.

Entities:  

Mesh:

Year:  1993        PMID: 8456431

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  23 in total

1.  Selectin-like kinetics and biomechanics promote rapid platelet adhesion in flow: the GPIb(alpha)-vWF tether bond.

Authors:  Teresa A Doggett; Gaurav Girdhar; Avril Lawshé; David W Schmidtke; Ian J Laurenzi; Scott L Diamond; Thomas G Diacovo
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

2.  VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.

Authors:  Daniel B Bellissimo; Pamela A Christopherson; Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Sandra L Haberichter; Amy D Shapiro; Thomas C Abshire; Cindy Leissinger; W Keith Hoots; Jeanne M Lusher; Margaret V Ragni; Robert R Montgomery
Journal:  Blood       Date:  2011-12-23       Impact factor: 22.113

3.  Integration of molecular and clinical data of 40 unrelated von Willebrand Disease families in a Spanish locus-specific mutation database: first release including 58 mutations.

Authors:  Irene Corrales; Lorena Ramírez; Júlia Ayats; Carme Altisent; Rafael Parra; Francisco Vidal
Journal:  Haematologica       Date:  2010-08-26       Impact factor: 9.941

4.  Mutation G1629E Increases von Willebrand Factor Cleavage via a Cooperative Destabilization Mechanism.

Authors:  Camilo Aponte-Santamaría; Svenja Lippok; Judith J Mittag; Tobias Obser; Reinhard Schneppenheim; Carsten Baldauf; Frauke Gräter; Ulrich Budde; Joachim O Rädler
Journal:  Biophys J       Date:  2017-01-10       Impact factor: 4.033

5.  Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease.

Authors:  R Schneppenheim; J Brassard; S Krey; U Budde; T J Kunicki; L Holmberg; J Ware; Z M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

6.  Linkage disequilibrium patterns vary with chromosomal location: a case study from the von Willebrand factor region.

Authors:  W S Watkins; R Zenger; E O'Brien; D Nyman; A W Eriksson; M Renlund; L B Jorde
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

7.  Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, alpha L beta 2) integrin.

Authors:  A Qu; D J Leahy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.

Authors:  T C Nichols; C M Samama; D A Bellinger; J Roussi; R L Reddick; M Bonneau; M S Read; O Bailliart; G G Koch; M Vaiman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Effects of the mutant von Willebrand factor gene in von Willebrand disease.

Authors:  Z Zhang; M Lindstedt; M Blombäck; M Anvret
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

10.  A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease.

Authors:  M V Ragni; R C Jankowitz; H L Chapman; E P Merricks; M T Kloos; A M Dillow; T C Nichols
Journal:  Haemophilia       Date:  2008-08-01       Impact factor: 4.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.